Post-Doctoral Training Fellow Biologist - Regulation of HSF1 in cancer cells
27/02/2019, 23:55
The ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top five cancer centres globally.
The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.
The Cancer Research UK Cancer Therapeutics Unit, within the Division of Cancer Therapeutics, is a multidisciplinary 'bench to bedside' centre, comprising around 160 staff dedicated to the discovery and development of novel therapeutics for the treatment of cancer. The Cancer Therapeutics Unit’s exciting goal is to discover high quality drug candidates for validated biological targets and to progress these candidates to clinical trial. All the scientific disciplines are in place to make this possible. Our biologists work alongside world-class chemists and drug metabolism specialists focusing on new molecular targets emerging from human genome and ground breaking cell biology research. This is an exciting and fast moving area of cancer research, and offers the opportunity to work within a multi-disciplinary environment using state-of-the-art techniques and equipment.
We are seeking a highly motivated Biologist to work in our Signal Transduction and Molecular Pharmacology (STMP) Team with Dr Paul Clarke & Professor Paul Workman, located in well-equipped laboratories in Sutton, South London. The successful applicant will use molecular, biochemical and cellular techniques to explore to validate potential molecular targets that regulate the transcriptional response to heat shock and other stresses in cancer cells.
Candidates should possess a PhD in Biochemistry, Molecular Biology or Cell Biology, have developed a range of skills through experience in these areas and be able to work in an interdisciplinary environment towards the goal of performing cellular and biochemical assays required for pathway analysis. Knowledge of cancer research and familiarity with contemporary approaches to drug discovery, molecular target validation is desirable.
Appointment will be to a Post-Doctoral Training Fellowship with starting salary in the range of £31,023 to £36,798 p.a. inclusive (based on previous experience). Appointment will be for 3 years in the first instance, and benefits from a contributory defined benefit pension scheme and generous leave entitlement. Further information can be found in the full job description at www.icr.ac.uk
We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.
The ICR is the leading academic research centre in the UK. Effective industry collaboration and innovation in new medicines and technologies are at the heart of our approach to drive benefits for patients. The ICR is ranked:
- first for the quality and impact of our research*
- second worldwide for the number of our publications cited in patents**
- fourth worldwide for the citation rate of scientific research published across all fields**
- fourth worldwide for top-cited research publications**
- in the top five higher education institutions worldwide for academic influence and commercial impact**
In partnership with
This Program is closed to applications.